Glabellar Rhytides
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides (NCT02261493) | Allergan | 2014-10-27 |
| A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides (NCT02261467) | Allergan | 2014-10-21 |
| Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines (NCT01814670) | Allergan | 2013-03-06 |
| A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows (NCT00752258) | Mentor Worldwide, LLC | 2008-02-01 |
| Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows (NCT00752050) | Mentor Worldwide, LLC | 2007-11-01 |
| Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows (NCT00752297) | Mentor Worldwide, LLC | 2007-06-01 |
Track Glabellar Rhytides automatically
Every clearance here is in the API, with alerts when new ones post.